newsfilter
← Latest News
ACCESS Newswire·

Lexaria's Oral GLP-1 Drug Strategy Validated by Industry

"The window to shape the oral GLP-1 market is open now...."Early-stage discussions with several multinational pharmaceutical companies currently underwayKELOWNA, BC / ACCESS Newswire / March 24, 2026 / Lexaria Bioscience